(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. This study reports on our experience with 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in pediatric patients affected by Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). We studied 20 pediatric subjects (12 males, 8 females mean age, 10 years